| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transition metal ion binding | APOBEC3D NR4A2 SLU7 FTMT ECE1 ME1 F8 APOBEC3B ZFP37 IFIH1 ACE2 P3H1 XPNPEP3 PAPPA ZMAT1 PRNP TRIM60 | 6.19e-05 | 1189 | 98 | 17 | GO:0046914 |
| Domain | TPR-contain_dom | 1.50e-05 | 150 | 99 | 7 | IPR013026 | |
| Domain | - | 1.17e-04 | 207 | 99 | 7 | 1.25.40.10 | |
| Domain | WW_DOMAIN_1 | 1.53e-04 | 51 | 99 | 4 | PS01159 | |
| Domain | WW_DOMAIN_2 | 1.53e-04 | 51 | 99 | 4 | PS50020 | |
| Domain | WW_dom | 1.65e-04 | 52 | 99 | 4 | IPR001202 | |
| Domain | LamGL | 1.66e-04 | 4 | 99 | 2 | SM00560 | |
| Domain | LamG-like | 1.66e-04 | 4 | 99 | 2 | IPR006558 | |
| Domain | TPR-like_helical_dom | 2.42e-04 | 233 | 99 | 7 | IPR011990 | |
| Domain | TPR_REGION | 2.47e-04 | 165 | 99 | 6 | PS50293 | |
| Domain | TPR | 2.47e-04 | 165 | 99 | 6 | PS50005 | |
| Domain | HECT | 3.85e-04 | 27 | 99 | 3 | PF00632 | |
| Domain | HECTc | 3.85e-04 | 27 | 99 | 3 | SM00119 | |
| Domain | HECT_dom | 3.85e-04 | 27 | 99 | 3 | IPR000569 | |
| Domain | HECT | 3.85e-04 | 27 | 99 | 3 | PS50237 | |
| Domain | DHC_N1 | 7.63e-04 | 8 | 99 | 2 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 7.63e-04 | 8 | 99 | 2 | IPR013594 | |
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 2.05e-06 | 130 | 99 | 6 | 35545047 | |
| Pubmed | NEDD4 E3 ligase inhibits the activity of the Hippo pathway by targeting LATS1 for degradation. | 4.83e-06 | 12 | 99 | 3 | 24107629 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | HMBOX1 FKBP15 CLASP1 IQGAP2 VPS45 NDUFAF3 NKRF WDR19 EFHC2 CNOT6L IFT88 XPNPEP3 DCAF11 EDRF1 DYNC1H1 | 4.93e-06 | 1321 | 99 | 15 | 27173435 |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | COL6A3 IQGAP2 DSG3 NIBAN2 ECE1 CYRIB ABCB1 ACE2 P3H1 MIF G6PD DYNC1H1 PRNP | 6.35e-06 | 1016 | 99 | 13 | 19056867 |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 37410361 | ||
| Pubmed | CYRI-B-mediated macropinocytosis drives metastasis via lysophosphatidic acid receptor uptake. | 8.02e-06 | 2 | 99 | 2 | 38712822 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 19099191 | ||
| Pubmed | Polymorphisms of the MDR1 and MIF genes in children with nephrotic syndrome. | 8.02e-06 | 2 | 99 | 2 | 21553324 | |
| Pubmed | Functional proteomics identifies targets of phosphorylation by B-Raf signaling in melanoma. | 8.02e-06 | 2 | 99 | 2 | 19362540 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 20583968 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 16988054 | ||
| Pubmed | WWP1 E3 ligase targets LATS1 for ubiquitin-mediated degradation in breast cancer cells. | 8.02e-06 | 2 | 99 | 2 | 23573293 | |
| Pubmed | APOBEC3 deletion increases the risk of breast cancer: a meta-analysis. | 2.40e-05 | 3 | 99 | 2 | 27602762 | |
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 22691411 | ||
| Pubmed | Studies on the restriction of murine leukemia viruses by mouse APOBEC3. | 2.40e-05 | 3 | 99 | 2 | 22666481 | |
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 20501672 | ||
| Pubmed | APOBEC3B and APOBEC3F inhibit L1 retrotransposition by a DNA deamination-independent mechanism. | 2.40e-05 | 3 | 99 | 2 | 16648136 | |
| Pubmed | Fv1 restriction and retrovirus vaccine immunity in Apobec3-deficient 129P2 mice. | 2.40e-05 | 3 | 99 | 2 | 23533681 | |
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 23315078 | ||
| Pubmed | Requirement for Fc effector mechanisms in the APOBEC3/Rfv3-dependent neutralizing antibody response. | 2.40e-05 | 3 | 99 | 2 | 25589647 | |
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 22628460 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 9765497 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 23449789 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 286744 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 25461681 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 24725948 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 23461902 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 284359 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 31801862 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 31943071 | ||
| Pubmed | Innate retroviral restriction by Apobec3 promotes antibody affinity maturation in vivo. | 2.40e-05 | 3 | 99 | 2 | 20566830 | |
| Pubmed | Chromosome mapping of Rfv3, a host resistance gene to Friend murine retrovirus. | 2.40e-05 | 3 | 99 | 2 | 7884913 | |
| Pubmed | N-linked glycosylation protects gammaretroviruses against deamination by APOBEC3 proteins. | 2.40e-05 | 3 | 99 | 2 | 25505062 | |
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 31595054 | ||
| Pubmed | Role of APOBEC3 in genetic diversity among endogenous murine leukemia viruses. | 2.40e-05 | 3 | 99 | 2 | 17967065 | |
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 20335265 | ||
| Pubmed | Deaminase-Dead Mouse APOBEC3 Is an In Vivo Retroviral Restriction Factor. | 2.40e-05 | 3 | 99 | 2 | 29593034 | |
| Pubmed | Noninfectious retrovirus particles drive the APOBEC3/Rfv3 dependent neutralizing antibody response. | 2.40e-05 | 3 | 99 | 2 | 21998583 | |
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 20829434 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 2157836 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 25986174 | ||
| Pubmed | Initial sequencing and comparative analysis of the mouse genome. | 2.40e-05 | 3 | 99 | 2 | 12466850 | |
| Pubmed | Murine Leukemia Virus P50 Protein Counteracts APOBEC3 by Blocking Its Packaging. | 2.40e-05 | 3 | 99 | 2 | 32641479 | |
| Pubmed | APOBEC3 deletion polymorphism is associated with epithelial ovarian cancer risk among Chinese women. | 2.40e-05 | 3 | 99 | 2 | 24577894 | |
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 1541833 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 27356895 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 23671100 | ||
| Pubmed | Structural perspectives on HIV-1 Vif and APOBEC3 restriction factor interactions. | 2.40e-05 | 3 | 99 | 2 | 31518043 | |
| Pubmed | APOBEC3 signature mutations in chronic lymphocytic leukemia. | 2.40e-05 | 3 | 99 | 2 | 24840555 | |
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 24453360 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 29362392 | ||
| Pubmed | APOBEC3-independent interferon-induced viral clearance in hepatitis B virus transgenic mice. | 2.40e-05 | 3 | 99 | 2 | 18434399 | |
| Pubmed | Induction of APOBEC3 in vivo causes increased restriction of retrovirus infection. | 2.40e-05 | 3 | 99 | 2 | 19153238 | |
| Pubmed | Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection. | 2.40e-05 | 3 | 99 | 2 | 18772436 | |
| Pubmed | Mouse APOBEC3 restricts friend leukemia virus infection and pathogenesis in vivo. | 2.40e-05 | 3 | 99 | 2 | 18786991 | |
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 20702647 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 20980520 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 20617165 | ||
| Pubmed | Apobec-mediated retroviral hypermutation in vivo is dependent on mouse strain. | 2.40e-05 | 3 | 99 | 2 | 39208378 | |
| Pubmed | HIF-1α-induced xenobiotic transporters promote Th17 responses in Crohn's disease. | 2.40e-05 | 3 | 99 | 2 | 30098863 | |
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 22454535 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 31830125 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 2922282 | ||
| Pubmed | Direct inhibition of human APOBEC3 deaminases by HIV-1 Vif independent of the proteolysis pathway. | 2.40e-05 | 3 | 99 | 2 | 38115583 | |
| Pubmed | Distinctive High Expression of Antiretroviral APOBEC3 Protein in Mouse Germinal Center B Cells. | 2.40e-05 | 3 | 99 | 2 | 35458563 | |
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 22275865 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 293683 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 19150103 | ||
| Pubmed | Serum- and glucocorticoid-inducible kinase SGK phosphorylates and negatively regulates B-Raf. | 2.40e-05 | 3 | 99 | 2 | 11410590 | |
| Pubmed | Fzd3 and Fzd6 deficiency results in a severe midbrain morphogenesis defect. | 2.87e-05 | 21 | 99 | 3 | 19842188 | |
| Pubmed | 4.65e-05 | 225 | 99 | 6 | 12168954 | ||
| Pubmed | Murine APOBEC1 is a powerful mutator of retroviral and cellular RNA in vitro and in vivo. | 4.79e-05 | 4 | 99 | 2 | 18983852 | |
| Pubmed | The extent of linkage disequilibrium caused by selection on G6PD in humans. | 4.79e-05 | 4 | 99 | 2 | 16020776 | |
| Pubmed | 4.79e-05 | 4 | 99 | 2 | 23725696 | ||
| Pubmed | 4.79e-05 | 4 | 99 | 2 | 21985787 | ||
| Pubmed | Human and murine APOBEC3s restrict replication of koala retrovirus by different mechanisms. | 4.79e-05 | 4 | 99 | 2 | 26253512 | |
| Pubmed | Reversed functional organization of mouse and human APOBEC3 cytidine deaminase domains. | 4.79e-05 | 4 | 99 | 2 | 17020885 | |
| Pubmed | 4.79e-05 | 4 | 99 | 2 | 16055735 | ||
| Pubmed | The incorporation of APOBEC3 proteins into murine leukemia viruses. | 4.79e-05 | 4 | 99 | 2 | 18572219 | |
| Pubmed | Immunoglobulin somatic hypermutation by APOBEC3/Rfv3 during retroviral infection. | 4.79e-05 | 4 | 99 | 2 | 24821801 | |
| Pubmed | Small molecular compounds inhibit HIV-1 replication through specifically stabilizing APOBEC3G. | 4.79e-05 | 4 | 99 | 2 | 20363737 | |
| Pubmed | Expression and subcellular localisation of AID and APOBEC3 in adenoid and palatine tonsils. | 4.79e-05 | 4 | 99 | 2 | 29343743 | |
| Pubmed | 4.79e-05 | 4 | 99 | 2 | 20538015 | ||
| Pubmed | The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance. | 4.79e-05 | 4 | 99 | 2 | 38049664 | |
| Pubmed | 4.79e-05 | 4 | 99 | 2 | 26507673 | ||
| Pubmed | Tetherin/BST-2 promotes dendritic cell activation and function during acute retrovirus infection. | 4.79e-05 | 4 | 99 | 2 | 26846717 | |
| Pubmed | 4.79e-05 | 4 | 99 | 2 | 28415995 | ||
| Pubmed | 4.79e-05 | 4 | 99 | 2 | 9223268 | ||
| Pubmed | Species-specific restriction of apobec3-mediated hypermutation. | 4.79e-05 | 4 | 99 | 2 | 18032489 | |
| Pubmed | Negative regulation of the serine/threonine kinase B-Raf by Akt. | 4.79e-05 | 4 | 99 | 2 | 10869359 | |
| Pubmed | Reassessment of murine APOBEC1 as a retrovirus restriction factor in vivo. | 4.79e-05 | 4 | 99 | 2 | 25303118 | |
| Pubmed | 4.79e-05 | 4 | 99 | 2 | 23555255 | ||
| Pubmed | 4.79e-05 | 4 | 99 | 2 | 36480186 | ||
| Pubmed | APOBEC3 regulates keratinocyte differentiation and expression of Notch3. | 4.79e-05 | 4 | 99 | 2 | 31400166 | |
| Pubmed | APOBEC3A functions as a restriction factor of human papillomavirus. | 4.79e-05 | 4 | 99 | 2 | 25355878 | |
| Pubmed | A second independent pathway for development of mesencephalic dopaminergic neurons requires Lmx1b. | 4.79e-05 | 4 | 99 | 2 | 10725922 | |
| Pubmed | 4.79e-05 | 4 | 99 | 2 | 20375169 | ||
| Pubmed | 4.79e-05 | 4 | 99 | 2 | 21147467 | ||
| Pubmed | 4.79e-05 | 4 | 99 | 2 | 16378963 | ||
| Pubmed | Inactivation of the Hippo tumor suppressor pathway promotes melanoma. | 4.79e-05 | 4 | 99 | 2 | 35768444 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.31e-07 | 138 | 97 | 8 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k4_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | COL6A3 RAPH1 IQGAP2 ME1 ITGB5 LPAR1 ACE2 SULF2 TENM4 PTPRD P3H1 SYNE2 RASGEF1B G6PD ZMAT1 | 2.03e-06 | 768 | 97 | 15 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | COL6A3 IQGAP2 VPS45 ME1 ITGB5 LPAR1 ACE2 SULF2 TENM4 P3H1 SYNE2 RASGEF1B PAPPA G6PD | 1.09e-05 | 773 | 97 | 14 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.77e-05 | 191 | 97 | 7 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k4_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_top-relative-expression-ranked_1000 | RAPH1 IQGAP2 SGK1 NR4A2 CASP7 NRROS ECE1 ME1 RGS2 APOBEC3B ABCB1 ACE2 RASGEF1B SP140 | 2.96e-05 | 846 | 97 | 14 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_1000 |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#1_top-relative-expression-ranked_100 | 4.04e-05 | 15 | 97 | 3 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_100_k1 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_500 | 4.39e-05 | 364 | 97 | 9 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#3_top-relative-expression-ranked_1000 | 6.11e-05 | 91 | 97 | 5 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k3_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | COL6A3 ME1 ITGB5 RGS2 LPAR1 ACE2 GXYLT2 SULF2 TENM4 PTPRD P3H1 SYNE2 ZMAT1 | 9.81e-05 | 827 | 97 | 13 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_DevVasTestis_Flk_top-relative-expression-ranked_1000 | RAPH1 SGK1 NR4A2 CASP7 MAGI3 NIBAN2 NRROS ECE1 ME1 RGS2 ABCB1 RASGEF1B SP140 | 1.24e-04 | 847 | 97 | 13 | gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_1000 |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#1_top-relative-expression-ranked_200 | 1.34e-04 | 22 | 97 | 3 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_200_k1 | |
| CoexpressionAtlas | dev gonad_e13.5_M_SertoliCell_Sox9_top-relative-expression-ranked_1000 | IQGAP2 FZD3 ME1 ITGB5 RGS2 APOBEC3B PTPRD P3H1 SYNE2 RASGEF1B PAPPA G6PD ZMAT1 | 1.81e-04 | 880 | 97 | 13 | gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | COL6A3 IQGAP2 ME1 ITGB5 LPAR1 ZFP37 ACE2 SULF2 TENM4 PTPRD P3H1 RASGEF1B | 2.18e-04 | 777 | 97 | 12 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | CLASP1 ECE1 RGS2 ABCB1 EFHC2 TENM4 CNOT6L MEIOC SYNE2 ATP11C HERC3 ZMAT1 | 2.21e-04 | 778 | 97 | 12 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.53e-04 | 123 | 97 | 5 | gudmap_developingGonad_e12.5_epididymis_k4_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | COL6A3 NR4A2 ME1 ITGB5 LPAR1 ZFP37 ACE2 SULF2 TENM4 PTPRD RASGEF1B G6PD | 2.63e-04 | 793 | 97 | 12 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | CLASP1 ECE1 RGS2 ABCB1 EFHC2 GXYLT2 TENM4 CNOT6L MEIOC SYNE2 DNAH8 ZMAT1 | 2.69e-04 | 795 | 97 | 12 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_ReproVasc_Flk_k-means-cluster#1_top-relative-expression-ranked_500 | 3.10e-04 | 29 | 97 | 3 | gudmap_dev gonad_e11.5_F_ReproVasc_Flk_k1_500 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Alveolar_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.94e-06 | 166 | 99 | 6 | 65dafed953b01a9830b54309af75c7a561e88336 | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 3.87e-06 | 187 | 99 | 6 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.50e-06 | 192 | 99 | 6 | 5c7e8b80b44d9ce55c797cdf8267ac5382e26cac | |
| ToppCell | P15-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.78e-06 | 194 | 99 | 6 | 5f04d21c4e2d36e74b6c5889aa97fd98f75a0973 | |
| ToppCell | LV-09._Endothelium_I|World / Chamber and Cluster_Paper | 4.92e-06 | 195 | 99 | 6 | 19e0a6c3eae1615aaa39767300acd937dfcb2a7f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.92e-06 | 195 | 99 | 6 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | LV-09._Endothelium_I|LV / Chamber and Cluster_Paper | 5.22e-06 | 197 | 99 | 6 | f9731d4d636e51b94a96805eee6afe9aedc175e3 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-early_osteoblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.37e-06 | 198 | 99 | 6 | 6a539d3b47bd2d4a7ad5c67cad23facffc0ac45f | |
| ToppCell | normal_Lung-Myeloid_cells-mo-Mac|Myeloid_cells / Location, Cell class and cell subclass | 5.37e-06 | 198 | 99 | 6 | fbd72ebaba73cc30e79dc8a8c3d46b6f863c1494 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_2-Endothelial_Tip.Dcn.1500015O10Rik_(1500015O10Rik)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.66e-06 | 114 | 99 | 5 | c3feca81edee445cbe5e46a07e1a59327dc2e981 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_2-Endothelial_Tip.Dcn.1500015O10Rik_(1500015O10Rik)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.66e-06 | 114 | 99 | 5 | 89350483d2ce57afc612fe25398e35af121d50f0 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-Mesenchymal-BMP_responsible_cell|1m / Sample Type, Dataset, Time_group, and Cell type. | 5.69e-06 | 200 | 99 | 6 | 06d615fe4b7dd5128dbdcd510a5ff3eb480c61b2 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.51e-05 | 155 | 99 | 5 | 77ae0b8d30bc3db4a73fd5340f99691a73d2684f | |
| ToppCell | normal_Lung-Myeloid_cells-CD163+CD14+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 3.48e-05 | 166 | 99 | 5 | 07b498eb341abec02a3ccaae320bdbb5cd6883c5 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.58e-05 | 167 | 99 | 5 | 805129f887078340b260aa136b0ba19f2bd6ea03 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.58e-05 | 167 | 99 | 5 | 31cf8bf2eb523f6e7e319620648ff37fc09e2601 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.58e-05 | 167 | 99 | 5 | 3acb18428d1d33ad430c2fd031b1a91baee3c01d | |
| ToppCell | ileum|World / shred on tissue and cell subclass | 3.90e-05 | 170 | 99 | 5 | 9f1211bd4287620e19a59f21e6ecdca3e42e0260 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.72e-05 | 177 | 99 | 5 | 1dc69c661e70e7e22bd9d7cf953eb638da9fd43c | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.72e-05 | 177 | 99 | 5 | 426a9845df7fd13b02e744532c336c60bc4d4a22 | |
| ToppCell | LA-17._Lymphocyte|World / Chamber and Cluster_Paper | 4.85e-05 | 178 | 99 | 5 | 34ec499d03cc198cfefa19a724d4c81974052f65 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.85e-05 | 178 | 99 | 5 | 8151e5d73407fd9cba382b69a2bc707c81790c7f | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_8|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.98e-05 | 179 | 99 | 5 | 163f5430d72ea0c1b239ea5d21e53be536636d3d | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_8|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.98e-05 | 179 | 99 | 5 | 0624dd537a68736f4d7b8b4de2c56168ed0e60a9 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Mac-Macrophage|bone_marrow / Manually curated celltypes from each tissue | 5.25e-05 | 181 | 99 | 5 | d2aa5b53162fb5c4cbbedbd2cb4b2b614e8c4afa | |
| ToppCell | LA-17._Lymphocyte|LA / Chamber and Cluster_Paper | 5.25e-05 | 181 | 99 | 5 | 3fd9f805fa46141b0fa7023ee5d8688d338635d5 | |
| ToppCell | P28-Mesenchymal|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.39e-05 | 182 | 99 | 5 | 69f9d44694fe4f55a971ae0ac5dc3e7448ee78f3 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.53e-05 | 183 | 99 | 5 | d73cac83cde82665f110baad7cf28db75f9ffe52 | |
| ToppCell | HSPCs-LMPPs|World / Lineage and Cell class | 5.53e-05 | 183 | 99 | 5 | e401f06843528a75693ce455bbeff2a98b8c24e5 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.68e-05 | 184 | 99 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | (2)_5-FU-(4)_COL2.3+_osteoblasts|World / Stress and Cell class | 5.68e-05 | 184 | 99 | 5 | 684d05340a3dfb8aa08b881516a37f9627a10448 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.68e-05 | 184 | 99 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.68e-05 | 184 | 99 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.98e-05 | 186 | 99 | 5 | 1bac7825c2fe3e6cdff65026b09b9ccaa40fa27f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.98e-05 | 186 | 99 | 5 | c7e2134454ab5d0885050dd1bb3c3bd15bf497ac | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.98e-05 | 186 | 99 | 5 | 59db239f1864a5d4f1570c93219dbd7ac5b6db35 | |
| ToppCell | Dendritic_Cells-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 5.98e-05 | 186 | 99 | 5 | 1d52912bd17e232cf39b2423a4d93585c164ba34 | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.13e-05 | 187 | 99 | 5 | ea9d34bcd3bd1f36745846309ede349773de501a | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 6.13e-05 | 187 | 99 | 5 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | IPF-Myeloid-DC_Mature|IPF / Disease state, Lineage and Cell class | 6.13e-05 | 187 | 99 | 5 | 63e0304a0183b69aebb0d1a4640a506a0d6fb6e9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.13e-05 | 187 | 99 | 5 | 9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7 | |
| ToppCell | COVID-19-kidney-Mito-rich_PCT|kidney / Disease (COVID-19 only), tissue and cell type | 6.13e-05 | 187 | 99 | 5 | 738ec2611b4be6a08eedad16b57fba84e1f11fef | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 6.29e-05 | 188 | 99 | 5 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.29e-05 | 188 | 99 | 5 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.29e-05 | 188 | 99 | 5 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | COPD-Myeloid-DC_Mature|COPD / Disease state, Lineage and Cell class | 6.29e-05 | 188 | 99 | 5 | de93ccb53edb8599da9e312db0e3af604c21f673 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.29e-05 | 188 | 99 | 5 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | Fetal_29-31_weeks-Immune-natural_killer_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.29e-05 | 188 | 99 | 5 | 6686dbba990066568aa7573e70a7db8b4758f457 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.29e-05 | 188 | 99 | 5 | cb091912f9b627a78a8793a37df7f1de839f887f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.44e-05 | 189 | 99 | 5 | 28b502611829e4a24caff2562545c7db97686099 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.61e-05 | 190 | 99 | 5 | 49e09cdb843b3d889a06a811aa5affae68b25a75 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.77e-05 | 191 | 99 | 5 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.77e-05 | 191 | 99 | 5 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | IPF-Myeloid-cDC2|World / Disease state, Lineage and Cell class | 6.77e-05 | 191 | 99 | 5 | 9fda87fb6bc5b8b6c0214ec909ebbc9f3f65319b | |
| ToppCell | COPD-Myeloid-cDC2|Myeloid / Disease state, Lineage and Cell class | 6.94e-05 | 192 | 99 | 5 | 984cdc2f1d93e164bc946d63f58dacb629f82eb7 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.94e-05 | 192 | 99 | 5 | e4dd24aefdf13cd4206714f02fde2288f3173ffc | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 6.94e-05 | 192 | 99 | 5 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.94e-05 | 192 | 99 | 5 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | IPF-Myeloid-cDC2|IPF / Disease state, Lineage and Cell class | 6.94e-05 | 192 | 99 | 5 | fe1de692fec48cba4a9bbc6eaa257260e8b4e800 | |
| ToppCell | (3)_Chondrocytes|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 6.94e-05 | 192 | 99 | 5 | 5d2b4830d025d3dbdf5623ce1c28d1036e1984a8 | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.11e-05 | 193 | 99 | 5 | ebd090d7801480b3cee45caac3d30cc991836769 | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.11e-05 | 193 | 99 | 5 | 22c58032e58730715224d7934968ce92d150b0e8 | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 7.11e-05 | 193 | 99 | 5 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | facs-MAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.11e-05 | 193 | 99 | 5 | f95b95c58a6edb8a03dd15ae166f47f9f33d8bd6 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 7.11e-05 | 193 | 99 | 5 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.11e-05 | 193 | 99 | 5 | 9fd2bc726bddf414f3de1c7a5ffd9317d3c98e29 | |
| ToppCell | facs-MAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.11e-05 | 193 | 99 | 5 | 85faf6c5ce4769615a4eca036e2ba307e176bb52 | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 7.11e-05 | 193 | 99 | 5 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Mesenchymal-mesenchymal_stem_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.11e-05 | 193 | 99 | 5 | 160691b671710be10220803d788c2c961c236af1 | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.11e-05 | 193 | 99 | 5 | 573ad2f848bede1fe20c7b4b352a9242ec294725 | |
| ToppCell | Control-Myeloid-Macrophage|Myeloid / Disease state, Lineage and Cell class | 7.11e-05 | 193 | 99 | 5 | 2a6d531abd34df20941cf3dac4fdfb1621a1bde6 | |
| ToppCell | RV-09._Endothelium_I|World / Chamber and Cluster_Paper | 7.11e-05 | 193 | 99 | 5 | e3fa47e2c7cd8a5b69186711c57751f2296de8ae | |
| ToppCell | facs-MAT-Fat-3m-Mesenchymal|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.11e-05 | 193 | 99 | 5 | 110a7d2ba7d066c2be38be98b643b76c520dd980 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.29e-05 | 194 | 99 | 5 | 9235849c7ef3236454eced413acff6274e991a0e | |
| ToppCell | E16.5-Endothelial|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.29e-05 | 194 | 99 | 5 | c048b7e08a08bb645a28c5b904bd87304d7a4f55 | |
| ToppCell | ILEUM-inflamed-(6)_ILC1|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.29e-05 | 194 | 99 | 5 | dc9ca407ec3ebec1a3dea1213a2beef28c1dc043 | |
| ToppCell | RV-09._Endothelium_I|RV / Chamber and Cluster_Paper | 7.29e-05 | 194 | 99 | 5 | 7b408096e717f2327c12aea35a8d5fc4621d3b06 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.29e-05 | 194 | 99 | 5 | 7062b152367987aba12a2f6f653b647c74b4e160 | |
| ToppCell | PBMC-Severe-cDC_5|Severe / Compartment, Disease Groups and Clusters | 7.29e-05 | 194 | 99 | 5 | b903e23eb75733ca516770727097fe74a9f8c1d1 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 7.29e-05 | 194 | 99 | 5 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.29e-05 | 194 | 99 | 5 | 855ddaf1ec91e6fe1f1617900216a5742e96dda2 | |
| ToppCell | LA-09._Endothelium_I|World / Chamber and Cluster_Paper | 7.47e-05 | 195 | 99 | 5 | fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4 | |
| ToppCell | Mesenchymal_cells-Fibro/Chondro_p.|Mesenchymal_cells / Lineage and Cell class | 7.47e-05 | 195 | 99 | 5 | b95a631d54c6cf85e48e1e638703206aaaebc073 | |
| ToppCell | 10x5'|World / Manually curated celltypes from each tissue | 7.47e-05 | 195 | 99 | 5 | de28b998793271c4f69ce9e183c3e62d809e9cc8 | |
| ToppCell | PBMC-Control-cDC_7|Control / Compartment, Disease Groups and Clusters | 7.47e-05 | 195 | 99 | 5 | c8f9f2911c2f963b5d1336fbb5567bfc7f3e737b | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.47e-05 | 195 | 99 | 5 | b072fdc2131173f562e55dd78226eaf2c57d3690 | |
| ToppCell | P15-Mesenchymal-myocytic_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.65e-05 | 196 | 99 | 5 | 41ae5b0d81ad09a6663335d899b4a1e4976c3b62 | |
| ToppCell | BL-critical-LOC-Lymphoid-NK|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.65e-05 | 196 | 99 | 5 | cfbeaabbeeb197f0cf8240a752d1f2995d59d7b7 | |
| ToppCell | normal_Lung-Myeloid_cells-mo-Mac|normal_Lung / Location, Cell class and cell subclass | 7.65e-05 | 196 | 99 | 5 | 4d3a3264b3d781139899448cde3b7a4f214ca14d | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.65e-05 | 196 | 99 | 5 | 028a06ed92f1c058dcbeacd335625bf529e87a7b | |
| ToppCell | Control-Myeloid-DC2|Control / Condition, Lineage and Cell class | 7.65e-05 | 196 | 99 | 5 | 0ccc26c2811e4c8631e0abd8555b167ac1e7a982 | |
| ToppCell | 10x5'-Liver-Lymphocytic_NK-NK_CD56bright_CD16-|Liver / Manually curated celltypes from each tissue | 7.65e-05 | 196 | 99 | 5 | 4ad73515af265432235b698fceb0ba370ced3e52 | |
| ToppCell | (2)_NK/T-(220)_CD8+_Cytotoxic_T_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 7.65e-05 | 196 | 99 | 5 | d123361c32bcd2329200f0316bc5b54bb494e92d | |
| ToppCell | ILEUM-inflamed-(7)_Endothelial_cell-(7)_CD36+_endothelial_cells|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.84e-05 | 197 | 99 | 5 | 66339b5aae3952f5c484c9dcb0cfb4fbd828d4cb | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.84e-05 | 197 | 99 | 5 | 24bcd56df43796af2833c7ce37719c76dd299c19 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.84e-05 | 197 | 99 | 5 | ea7dd7f90be34d8e5936c9c8d35e0918ae64433b | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 7.84e-05 | 197 | 99 | 5 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.84e-05 | 197 | 99 | 5 | 26475b9e4d6bfc0ae818dea13d139888ed7e92f1 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.84e-05 | 197 | 99 | 5 | 0c8650bde08e1317baee4793201645d86f16e15d | |
| ToppCell | LA-09._Endothelium_I|LA / Chamber and Cluster_Paper | 7.84e-05 | 197 | 99 | 5 | ab6d1ab586a188597a39854ef980b8955ebcc645 | |
| Disease | susceptibility to mononucleosis measurement | 2.97e-06 | 69 | 95 | 5 | EFO_0008403 | |
| Disease | Malignant neoplasm of breast | RAPH1 CASP7 MANEA RGS2 APOBEC3B LPAR1 ABCB1 SULF2 PTPRD BRAF TMTC4 SYNE2 MIF NMBR | 8.64e-06 | 1074 | 95 | 14 | C0006142 |
| Disease | Breast Carcinoma | 6.10e-05 | 538 | 95 | 9 | C0678222 | |
| Disease | thyroid peroxidase antibody measurement | 8.77e-05 | 72 | 95 | 4 | EFO_0005666 | |
| Disease | congenital muscular dystrophy (implicated_via_orthology) | 1.53e-04 | 6 | 95 | 2 | DOID:0050557 (implicated_via_orthology) | |
| Disease | Liver Cirrhosis, Experimental | 1.97e-04 | 774 | 95 | 10 | C0023893 | |
| Disease | Colorectal Neoplasms | 2.80e-04 | 277 | 95 | 6 | C0009404 | |
| Disease | Mammary Carcinoma, Human | 2.99e-04 | 525 | 95 | 8 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 2.99e-04 | 525 | 95 | 8 | C1257931 | |
| Disease | Mammary Neoplasms | 3.06e-04 | 527 | 95 | 8 | C1458155 | |
| Disease | cystic fibrosis (implicated_via_orthology) | 3.64e-04 | 9 | 95 | 2 | DOID:1485 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | 4.41e-04 | 702 | 95 | 9 | C0009402 | |
| Disease | Ciliopathies | 4.48e-04 | 110 | 95 | 4 | C4277690 | |
| Disease | cholestasis (biomarker_via_orthology) | 5.35e-04 | 49 | 95 | 3 | DOID:13580 (biomarker_via_orthology) | |
| Disease | granulosa cell tumor (is_marker_for) | 5.54e-04 | 11 | 95 | 2 | DOID:2999 (is_marker_for) | |
| Disease | Paranoia | 5.54e-04 | 11 | 95 | 2 | C1456784 | |
| Disease | hyperhomocysteinemia (implicated_via_orthology) | 5.54e-04 | 11 | 95 | 2 | DOID:9279 (implicated_via_orthology) | |
| Disease | blood nickel measurement | 6.23e-04 | 120 | 95 | 4 | EFO_0007583 | |
| Disease | Parkinson Disease, Secondary Vascular | 6.63e-04 | 12 | 95 | 2 | C0751414 | |
| Disease | Atherosclerotic Parkinsonism | 6.63e-04 | 12 | 95 | 2 | C0751415 | |
| Disease | Secondary Parkinson Disease | 6.63e-04 | 12 | 95 | 2 | C0030569 | |
| Disease | Behavior Disorders | 6.63e-04 | 12 | 95 | 2 | C0004930 | |
| Disease | Mental disorders | 6.63e-04 | 12 | 95 | 2 | C0004936 | |
| Disease | Dental enamel hypoplasia | 6.63e-04 | 12 | 95 | 2 | EFO_1001304 | |
| Disease | Mental Disorders, Severe | 6.63e-04 | 12 | 95 | 2 | C4046029 | |
| Disease | Diagnosis, Psychiatric | 6.63e-04 | 12 | 95 | 2 | C0376338 | |
| Disease | pursuit maintenance gain measurement | 6.83e-04 | 123 | 95 | 4 | EFO_0008433 | |
| Disease | Acute Myeloid Leukemia, M1 | 7.26e-04 | 125 | 95 | 4 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 7.26e-04 | 125 | 95 | 4 | C1879321 | |
| Disease | Nephronophthisis | 7.82e-04 | 13 | 95 | 2 | C0687120 | |
| Disease | Malignant Neoplasms | 7.93e-04 | 128 | 95 | 4 | C0006826 | |
| Disease | Prostatic Neoplasms | 8.53e-04 | 616 | 95 | 8 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 8.53e-04 | 616 | 95 | 8 | C0376358 | |
| Disease | autosomal dominant polycystic kidney disease (implicated_via_orthology) | 9.10e-04 | 14 | 95 | 2 | DOID:898 (implicated_via_orthology) | |
| Disease | Juvenile-Onset Still Disease | 9.67e-04 | 135 | 95 | 4 | C0087031 | |
| Disease | hepatic encephalopathy (biomarker_via_orthology) | 1.05e-03 | 15 | 95 | 2 | DOID:13413 (biomarker_via_orthology) | |
| Disease | non-alcoholic fatty liver disease (biomarker_via_orthology) | 1.22e-03 | 65 | 95 | 3 | DOID:0080208 (biomarker_via_orthology) | |
| Disease | obsolete_red blood cell distribution width | CLASP1 ECE1 F8 PAIP1 APOBEC3B CYRIB ABCB1 SYNE2 THG1L ATP11C OSBP2 G6PD | 1.29e-03 | 1347 | 95 | 12 | EFO_0005192 |
| Disease | Vitiligo | 1.35e-03 | 17 | 95 | 2 | C0042900 | |
| Disease | Adrenocortical carcinoma | 1.52e-03 | 18 | 95 | 2 | C0206686 | |
| Disease | Unipolar Depression | 1.53e-03 | 259 | 95 | 5 | C0041696 | |
| Disease | childhood trauma measurement, alcohol consumption measurement | 1.58e-03 | 71 | 95 | 3 | EFO_0007878, EFO_0007979 | |
| Disease | cardiomyopathy (implicated_via_orthology) | 1.58e-03 | 71 | 95 | 3 | DOID:0050700 (implicated_via_orthology) | |
| Disease | colorectal cancer, inflammatory bowel disease | 1.69e-03 | 19 | 95 | 2 | EFO_0003767, MONDO_0005575 | |
| Disease | pentachlorophenol measurement | 1.71e-03 | 73 | 95 | 3 | EFO_0022071 | |
| Disease | parathion measurement | 1.71e-03 | 73 | 95 | 3 | EFO_0022070 | |
| Disease | potassium chromate measurement | 1.71e-03 | 73 | 95 | 3 | EFO_0022072 | |
| Disease | mercuric chloride measurement | 1.71e-03 | 73 | 95 | 3 | EFO_0022068 | |
| Disease | heptachlor epoxide measurement | 1.71e-03 | 73 | 95 | 3 | EFO_0022067 | |
| Disease | methoxychlor measurement | 1.71e-03 | 73 | 95 | 3 | EFO_0022069 | |
| Disease | 4,6-dinitro-o-cresol measurement | 1.71e-03 | 73 | 95 | 3 | EFO_0022053 | |
| Disease | 2,4,5-trichlorophenol measurement | 1.71e-03 | 73 | 95 | 3 | EFO_0022052 | |
| Disease | azinphos methyl measurement | 1.71e-03 | 73 | 95 | 3 | EFO_0022055 | |
| Disease | aldrin measurement | 1.71e-03 | 73 | 95 | 3 | EFO_0022054 | |
| Disease | dicofol measurement | 1.71e-03 | 73 | 95 | 3 | EFO_0022060 | |
| Disease | disulfoton measurement | 1.71e-03 | 73 | 95 | 3 | EFO_0022062 | |
| Disease | dieldrin measurement | 1.71e-03 | 73 | 95 | 3 | EFO_0022061 | |
| Disease | endrin measurement | 1.71e-03 | 73 | 95 | 3 | EFO_0022064 | |
| Disease | endosulfan measurement | 1.71e-03 | 73 | 95 | 3 | EFO_0022063 | |
| Disease | heptachlor measurement | 1.71e-03 | 73 | 95 | 3 | EFO_0022066 | |
| Disease | ethion measurement | 1.71e-03 | 73 | 95 | 3 | EFO_0022065 | |
| Disease | chlorpyrifos measurement | 1.71e-03 | 73 | 95 | 3 | EFO_0022057 | |
| Disease | cadmium chloride measurement | 1.71e-03 | 73 | 95 | 3 | EFO_0022056 | |
| Disease | diazinon measurement | 1.71e-03 | 73 | 95 | 3 | EFO_0022059 | |
| Disease | dibutyl phthalate measurement | 1.71e-03 | 73 | 95 | 3 | EFO_0022058 | |
| Disease | environmental exposure measurement | 1.71e-03 | 73 | 95 | 3 | EFO_0008360 | |
| Disease | DDT metabolite measurement | 1.78e-03 | 74 | 95 | 3 | EFO_0007886 | |
| Disease | epilepsy (biomarker_via_orthology) | 2.07e-03 | 21 | 95 | 2 | DOID:1826 (biomarker_via_orthology) | |
| Disease | kidney disease (biomarker_via_orthology) | 2.07e-03 | 21 | 95 | 2 | DOID:557 (biomarker_via_orthology) | |
| Disease | Schizophrenia | 2.19e-03 | 883 | 95 | 9 | C0036341 | |
| Disease | brain infarction, neuritic plaque measurement, Lewy body dementia, cerebral amyloid angiopathy, neurofibrillary tangles measurement | 2.27e-03 | 22 | 95 | 2 | EFO_0004277, EFO_0006790, EFO_0006792, EFO_0006797, EFO_0006798 | |
| Disease | Leukemia, Myelocytic, Acute | 2.40e-03 | 173 | 95 | 4 | C0023467 | |
| Disease | bipolar disorder | 2.65e-03 | 577 | 95 | 7 | MONDO_0004985 | |
| Disease | malaria (is_implicated_in) | 2.70e-03 | 24 | 95 | 2 | DOID:12365 (is_implicated_in) | |
| Disease | Cerebral Astrocytoma | 2.93e-03 | 25 | 95 | 2 | C0750935 | |
| Disease | Intracranial Astrocytoma | 2.93e-03 | 25 | 95 | 2 | C0750936 | |
| Disease | Astrocytoma | 2.93e-03 | 25 | 95 | 2 | C0004114 | |
| Disease | Grade I Astrocytoma | 2.93e-03 | 25 | 95 | 2 | C1704230 | |
| Disease | Subependymal Giant Cell Astrocytoma | 2.93e-03 | 25 | 95 | 2 | C0205768 | |
| Disease | Mixed oligoastrocytoma | 2.93e-03 | 25 | 95 | 2 | C0547065 | |
| Disease | Pilocytic Astrocytoma | 2.93e-03 | 25 | 95 | 2 | C0334583 | |
| Disease | Juvenile Pilocytic Astrocytoma | 2.93e-03 | 25 | 95 | 2 | C0280783 | |
| Disease | Diffuse Astrocytoma | 2.93e-03 | 25 | 95 | 2 | C0280785 | |
| Disease | Childhood Cerebral Astrocytoma | 2.93e-03 | 25 | 95 | 2 | C0338070 | |
| Disease | Gemistocytic astrocytoma | 3.17e-03 | 26 | 95 | 2 | C0334581 | |
| Disease | Protoplasmic astrocytoma | 3.17e-03 | 26 | 95 | 2 | C0334580 | |
| Disease | Fibrillary Astrocytoma | 3.17e-03 | 26 | 95 | 2 | C0334582 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RMQDKNPYSFQSDVY | 626 | P15056 | |
| RMYRDTFYDNFENEP | 11 | Q96AK3 | |
| RMYRDTFYDNFENEP | 11 | Q9UH17 | |
| YGLSMDFNSPNDYNK | 146 | Q68CP9 | |
| NYNSPKFRSRNQSYM | 501 | Q9P1A6 | |
| AANEDYNLYTFDMRA | 256 | Q9NV06 | |
| NMANFSYRFSIYNLN | 61 | Q70E73 | |
| QYDDAASYQRLNSHM | 111 | P11413 | |
| FPNDEVMNQNLAYYA | 331 | Q32P28 | |
| FYEDQYGVALFNSMR | 31 | Q96TA1 | |
| FEHMYAQSLQVPYRN | 916 | P08183 | |
| YYPNLSLEDMLNRSN | 281 | Q9H477 | |
| ALAMQHYEQTAPFNY | 1206 | O60840 | |
| NDNFPMFRDSQYSAR | 261 | P32926 | |
| YMYRSFNYNEIDPSL | 286 | P28336 | |
| RSQMYSTDYDQILPD | 541 | P48163 | |
| PSYNQTNSSMDFRNY | 271 | Q5TCQ9 | |
| YYQSGDHPRQDSMDF | 861 | O95835 | |
| YYSANNLNVFLMGER | 141 | P59045 | |
| YFTMATLQQDYAPLS | 971 | Q3B7T1 | |
| YENYSPAVDFRTMNQ | 381 | Q15034 | |
| YSYNPDQFHNMDLRG | 41 | Q76N89 | |
| EFNSAMNPIIYSYRD | 301 | Q92633 | |
| MANYRYFLEETGPNS | 451 | O95822 | |
| DQEAYFRYMAENPTA | 156 | Q86XP3 | |
| VMESYFNENQYPDEA | 281 | Q6NT76 | |
| LNYMEQNTDKYPFSN | 531 | Q5JST6 | |
| YAVADNAYNDMLRNR | 196 | A7E2Y1 | |
| QYRQAEYFQDDMPES | 511 | Q8TEB1 | |
| LQPYFNMDDYTFESA | 3246 | Q96JB1 | |
| ELMVRPNNYSTFYDD | 131 | Q5T1M5 | |
| NAQSFQPYAGMQAYA | 456 | Q5T1M5 | |
| FQDNLFQSMYYPLQL | 386 | A0PJZ3 | |
| MVTFRNQASRPYSFY | 1791 | P00451 | |
| SPDRVYINYYDMNAA | 91 | P14174 | |
| SFFNTPYNNFMSYAD | 626 | Q13219 | |
| EHQMDPSSNFYNYRT | 336 | Q0VAM2 | |
| NEYTASNQMDYPSLA | 306 | P18084 | |
| LPENAENMYYFSELA | 791 | Q969R2 | |
| FHIEPYSNRDDQNMY | 221 | Q5SRI9 | |
| YREATPENDPNYFMN | 386 | Q9H074 | |
| DMNNYAPEFTVKSYN | 2541 | Q6V1P9 | |
| ENYDPMDSVALNTAY | 121 | O15439 | |
| FNLASQYSVNEMYAE | 201 | Q13099 | |
| MNDPQLSFLDAYRNY | 1601 | Q8TD26 | |
| TRPEFYLNSYMNKQD | 1076 | P12111 | |
| MSNGYSTDENFRYLI | 1 | Q9BYX4 | |
| NDNEMYLFRSSVAYA | 636 | Q9BYF1 | |
| TRDRVPTYQYNMNFE | 51 | P55210 | |
| YNTTFMPNLLNHYDQ | 41 | Q9NPG1 | |
| YAGYFDQQMRQNLFT | 3516 | Q14204 | |
| KMTNPAIQNDFSYYR | 146 | Q9NUQ9 | |
| NDYTAVPDLYFENAM | 521 | P42892 | |
| NSMIRYYKNNFSDGF | 476 | Q9NTJ5 | |
| NQYFHISMLDYNARD | 436 | Q96PB7 | |
| SMAYYFSRDDVALNN | 96 | Q8N4E7 | |
| DNNMGFYRDLYNTSS | 281 | Q86YC3 | |
| MVQTEDQYQFSYRAA | 1886 | P23468 | |
| EASSEPDYNYEFAQM | 571 | Q9H1H9 | |
| SLDYSRFQANPDYQM | 381 | P43354 | |
| MFLSQFNRYNENVDY | 311 | A2RUB1 | |
| YNTERNTFMYNDTGL | 4216 | O75445 | |
| MENNSYPRFLESEFY | 181 | P41220 | |
| RAVEPAQQYDMFNIY | 621 | Q9HCS7 | |
| VYLMNQYLETNSFPS | 31 | Q8N4H0 | |
| YNAFPEENMNYANGF | 1466 | A2VDJ0 | |
| NNFARSFYPMLRYTN | 6866 | Q8WXH0 | |
| QTHFASMPRDIYQDY | 86 | O15226 | |
| SMPRDIYQDYTQDSF | 91 | O15226 | |
| SMYFEQPDSFQHYRS | 616 | Q8N660 | |
| VYPFAAAMYQNELFN | 336 | Q13576 | |
| MQQSSYNAFSLHNPY | 501 | Q96SF7 | |
| PFYSRNTAEMYDNIL | 296 | O00141 | |
| QERYPNNSMFNEVYG | 941 | Q92540 | |
| MYPNQRDSAYSSFSA | 181 | Q9ULL8 | |
| LAMFTNDYNLAQDLY | 726 | Q8NEZ3 | |
| QQFTREIFDMYQNYS | 201 | O75570 | |
| YSPSMLDYDTENLNS | 1161 | Q7Z460 | |
| ENNLMPYTNYTFDFK | 471 | Q96LI5 | |
| SQQPLYDAAYLTMYN | 901 | Q8NB49 | |
| QDDFVNFTDYSYQMR | 161 | Q8NEY3 | |
| SFADSMLVRAVNYNY | 306 | Q5T4D3 | |
| QREAAQAMYIDSYNS | 51 | Q9BU61 | |
| FSEFNINYNNELPMY | 221 | Q9NWX6 | |
| NGYMRITNENFVDAY | 91 | Q9Y5Y6 | |
| VYYRPMDEYSNQNNF | 161 | P04156 | |
| MVNARFDYNYDNSFR | 2076 | Q6N022 | |
| FDYNYDNSFRVTSMQ | 2081 | Q6N022 | |
| NSAYYDPKTRAMREN | 281 | O95391 | |
| FYANNMYLNFAEIGS | 271 | Q9NRW7 | |
| YELGDLSFYNMNDRS | 421 | Q495X7 | |
| RNTPAYFNSMIQGYT | 821 | Q8TE23 | |
| NNQRYAFMPLIDDSD | 456 | Q96K49 | |
| YMSNDIPYTFHQDNN | 106 | Q9NQH7 | |
| TNQDDIFYAYASMSP | 31 | Q6ZS52 | |
| MAYPDLNEIYRSFQN | 121 | Q13342 | |
| QFNQRYLYSASMLAA | 436 | Q9H0M0 | |
| PAQSNLYNDVMLENY | 51 | Q9Y6Q3 | |
| YFDLNTDPYQLMNAV | 781 | Q8IWU5 | |
| QDRDNCMGYQYPFTL | 941 | P35125 | |
| QARPNNAYTAMSDSY | 41 | Q9Y5A9 | |
| TFRTYAAPYNISQAM | 276 | Q5H9K5 | |
| GNPIDRLYSMQSSYF | 386 | O60663 |